Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Gastric Cancer

Free Subscription 01.09.2025 3 Anticancer Res 3 BMC Cancer 1 BMC Gastroenterol 1 Br J Cancer 1 Endoscopy

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Anticancer Res

1. LEE YJ, Baek JH, Kim JG, Park KB, et al
   Clinical Significance of PD-L1, LAG3, and VISTA in Patients With Poorly Cohesive Cell Gastric Cancer.
   Anticancer Res. 2025;45:3939-3951.
   PubMed         Abstract available
   
   
2. TAKABATAKE K, Kubota T, Inoue H, Nishibeppu K, et al
   Prevalence and Clinical Impact of Severe Periodontitis in Patients With Gastric Cancer.
   Anticancer Res. 2025;45:3885-3894.
   PubMed         Abstract available
   
   
3. KATAYAMA R, Aoki T, Matsuda K, Yamazaki K, et al
   Assessment of Remnant Gastric Perfusion Using Indocyanine Green During Pancreaticoduodenectomy After Gastrectomy: A Case Report.
   Anticancer Res. 2025;45:4057-4062.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. SHANSHAN W, Lian W, Lu D, Liping L, et al
   Best practices for home nutritional management in postoperative gastric cancer patients: an evidence summary.
   BMC Cancer. 2025;25:1399.
   PubMed         Abstract available
   
   
5. ZHANG R, Chen X, Chen G, Zhao Z, et al
   Novel surveillance protocol for gastric cancer based on CEA: a high-volume multi-center study.
   BMC Cancer. 2025;25:1396.
   PubMed         Abstract available
   
   
6. ZENG T, Ling X, Chen S, Yang J, et al
   Prognostic value of nutritional risk assessment indices in patients with digestive system tumors.
   BMC Cancer. 2025;25:1385.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

7. WANG X, Jiang H, Liang M, Cai D, et al
   A Multi-marker model based on serum IL-10 predicts response to conversion immunochemotherapy in gastric cancer patients: a retrospective cohort study.
   BMC Gastroenterol. 2025;25:621.
   PubMed         Abstract available
   
   

   
   Br J Cancer

8. LI L, Yin J, Zhang L, Liu W, et al
   Aberrant PJA2-CHRM3 signaling creates a therapeutic vulnerability in gastric tumor.
   Br J Cancer. 2025 Aug 26. doi: 10.1038/s41416-025-03145.
   PubMed         Abstract available
   
   

   
   Endoscopy

9. SONG S, Liu H, Geng X, Chen R, et al
   Assessment of the participation rate and effectiveness of upper gastrointestinal cancer screening in China: a multicenter population-based screening study.
   Endoscopy. 2025;57:972-979.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.